As of 2025-12-21, the Relative Valuation of Adicet Bio Inc (ACET) is (13.71) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.49 USD, the upside of Adicet Bio Inc based on Relative Valuation is -2876.9%.
The range of the Relative Valuation is (13.74) - (13.70) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.6x - 17.8x | 17.7x |
| Forward P/E multiples | 17.8x - 17.9x | 17.8x |
| Fair Price | (13.74) - (13.70) | (13.71) |
| Upside | -2883.9% - -2874.5% | -2876.9% |
| Date | P/E |
| 2025-12-19 | -0.64 |
| 2025-12-18 | -0.61 |
| 2025-12-17 | -0.61 |
| 2025-12-16 | -0.60 |
| 2025-12-15 | -0.64 |
| 2025-12-12 | -0.65 |
| 2025-12-11 | -0.67 |
| 2025-12-10 | -0.71 |
| 2025-12-09 | -0.70 |
| 2025-12-08 | -0.68 |
| 2025-12-05 | -0.69 |
| 2025-12-04 | -0.72 |
| 2025-12-03 | -0.70 |
| 2025-12-02 | -0.73 |
| 2025-12-01 | -0.79 |
| 2025-11-28 | -0.84 |
| 2025-11-26 | -0.78 |
| 2025-11-25 | -0.78 |
| 2025-11-24 | -0.79 |
| 2025-11-21 | -0.78 |
| 2025-11-20 | -0.75 |
| 2025-11-19 | -0.75 |
| 2025-11-18 | -0.78 |
| 2025-11-17 | -0.77 |
| 2025-11-14 | -0.86 |
| 2025-11-13 | -0.86 |
| 2025-11-12 | -0.89 |
| 2025-11-11 | -0.84 |
| 2025-11-10 | -0.85 |
| 2025-11-07 | -0.83 |
| 2025-11-06 | -0.88 |
| 2025-11-05 | -0.89 |
| 2025-11-04 | -0.90 |
| 2025-11-03 | -0.95 |
| 2025-10-31 | -0.97 |
| 2025-10-30 | -1.01 |
| 2025-10-29 | -0.97 |
| 2025-10-28 | -1.11 |
| 2025-10-27 | -1.17 |
| 2025-10-24 | -1.15 |
| 2025-10-23 | -1.12 |
| 2025-10-22 | -1.18 |
| 2025-10-21 | -1.20 |
| 2025-10-20 | -1.28 |
| 2025-10-17 | -1.28 |
| 2025-10-16 | -1.35 |
| 2025-10-15 | -1.28 |
| 2025-10-14 | -1.24 |
| 2025-10-13 | -1.27 |
| 2025-10-10 | -1.25 |